All Articles
Showing 61–72 of 77 articles.
CDC Report Details Age-Adjusted Cardiovascular Disease Prevalence and Modifiable Risk Factors in U.S. Men
CDC Report Details Age-Adjusted Cardiovascular Disease Prevalence and Modifiable Risk Factors in U.S. Men
Read More →Peer-Reviewed Studies Examine Accuracy of Consumer Wearables for Heart Rate, Blood Pressure, and Sleep Tracking in Adult Males
Validation Studies From 2022-2024 Report Accuracy Metrics for Wearable Heart Rate, Atrial Fibrillation Detection, and Sleep Tracking in Men
Read More →FDA Outlines Regulatory Expectations for AI Tools Used in Heart Disease Prediction
FDA Outlines Regulatory Expectations for AI Tools Used in Heart Disease Prediction
Read More →What Pooled Primary Data Show About Consumer Wearables in Prevention Strategies
What Pooled Primary Data Show About Consumer Wearables in Prevention Strategies
Read More →Latest CDC Data Show Persistent Gaps in Men's Weekly Activity Meeting Federal Guidelines
Latest CDC Data Show Persistent Gaps in Men's Weekly Activity Meeting Federal Guidelines
Read More →CDC Data on Leading Heart Disease Risks for Men
CDC and MMWR Reports on Cardiovascular Risk Factors in Men
Read More →What CDC and WHO Primary Reports State About Daily Sitting Time and Health Metrics
What CDC and WHO Primary Reports State About Daily Sitting Time and Health Metrics
Read More →Wearable Trackers Linked to Modest Improvements in Activity and Metabolic Markers in Men, Literature Review Finds
Wearable Trackers Linked to Modest Improvements in Activity and Metabolic Markers in Men, Literature Review Finds
Read More →FDA Clarifies Evidence Standards for Digital Tools Used in Remote Monitoring and Preventive Health
FDA Clarifies Evidence Standards for Digital Tools Used in Remote Monitoring and Preventive Health
Read More →Published Trials Report Lean Mass Reductions Associated with GLP-1 Agonist Use in Men with Obesity
Published Trials Report Lean Mass Reductions Associated with GLP-1 Agonist Use in Men with Obesity
Read More →FDA Warns of Adverse Events Linked to Unapproved Compounded Versions of Ozempic and Wegovy
FDA Warns of Adverse Events Linked to Unapproved Compounded Versions of Ozempic and Wegovy
Read More →What Peer-Reviewed Evidence Shows About Strength Training and Hormonal Response
What Peer-Reviewed Evidence Shows About Strength Training and Hormonal Response
Read More →